全文获取类型
收费全文 | 131339篇 |
免费 | 9846篇 |
国内免费 | 3767篇 |
专业分类
耳鼻咽喉 | 1027篇 |
儿科学 | 2427篇 |
妇产科学 | 1909篇 |
基础医学 | 8112篇 |
口腔科学 | 2919篇 |
临床医学 | 15272篇 |
内科学 | 19246篇 |
皮肤病学 | 2360篇 |
神经病学 | 7487篇 |
特种医学 | 4120篇 |
外国民族医学 | 40篇 |
外科学 | 13480篇 |
综合类 | 18696篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5640篇 |
眼科学 | 2268篇 |
药学 | 10725篇 |
77篇 | |
中国医学 | 11183篇 |
肿瘤学 | 17939篇 |
出版年
2024年 | 328篇 |
2023年 | 2317篇 |
2022年 | 4223篇 |
2021年 | 5721篇 |
2020年 | 5364篇 |
2019年 | 4792篇 |
2018年 | 4519篇 |
2017年 | 5000篇 |
2016年 | 5317篇 |
2015年 | 5139篇 |
2014年 | 9204篇 |
2013年 | 11671篇 |
2012年 | 7604篇 |
2011年 | 8104篇 |
2010年 | 6735篇 |
2009年 | 6211篇 |
2008年 | 6128篇 |
2007年 | 6522篇 |
2006年 | 5860篇 |
2005年 | 5193篇 |
2004年 | 4259篇 |
2003年 | 3850篇 |
2002年 | 3137篇 |
2001年 | 2775篇 |
2000年 | 2294篇 |
1999年 | 1789篇 |
1998年 | 1502篇 |
1997年 | 1278篇 |
1996年 | 1073篇 |
1995年 | 969篇 |
1994年 | 754篇 |
1993年 | 587篇 |
1992年 | 519篇 |
1991年 | 483篇 |
1990年 | 413篇 |
1989年 | 357篇 |
1988年 | 353篇 |
1987年 | 301篇 |
1986年 | 258篇 |
1985年 | 325篇 |
1984年 | 275篇 |
1983年 | 218篇 |
1982年 | 228篇 |
1981年 | 223篇 |
1980年 | 181篇 |
1979年 | 164篇 |
1978年 | 115篇 |
1977年 | 67篇 |
1976年 | 76篇 |
1975年 | 55篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
BACKGROUND: Patient education is integral part of any diabetes therapy in Germany, but elderly patients are not able to follow the variety of topics comprising standard treatment and teaching programmes (TTP), primarily due to impaired neuropsychological function. This leads to deficits in diabetes knowledge and hindered ability for diabetes self-management. AIM: To evaluate structured TTP for geriatric patients with impaired cognitive function. PATIENTS AND METHODS: A neuropsychological examination was performed on all patients over 54 years [n=102, age 68.6 +/- 8.7 years, diabetes duration 10.3 (0.03-35.4) years, HbA1c 10.3 +/- 1.7% (HPLC, Diamat, NR 4.5-6.3%), cognitive function 87.7 +/- 12.3 IQ points] who took part in TTP for insulin therapy. Patients with impaired cognitive function participated either in the standard TTP of Berger [n = 35, age 67.6 +/- 8.9 years, diabetes duration 9.9 (0.04-35.4) years, HbA1c 10.3 +/- 2.0%] or in the specialized structured geriatric DICOF-TTP [n=33, age 70.4 +/- 8.2 years, diabetes duration 10.4 (0.03-24.9) years, HbA1c 10.7 +/- 1.8%]. RESULTS: After TTP there were no differences in knowledge and ability for diabetes self-management (standard/DICOF: knowledge 11.0 +/- 2.6 vs. 12.2 +/- 2.7 points, P = 0.11; handling 14.9 +/- 3.3 vs. 15.9 +/- 2.5 points, P = 0.18). However, patients who took part in the DICOF programme showed better scores in satisfaction with the education programme [standard/DICOF 44.7 (31-57) vs. 52.5 (45-59) points, P < 0.001]. Six months later the DICOF participants showed better results regarding diabetes self-management (standard/DICOF: handling 12.5 +/- 4.1 vs. 15.9 +/- 3.1 points, P = 0.001). Both groups showed HbA1c decrease (8.3 +/- 1.4 vs. 8.5 +/- 1.3%, P=0.62) and similar incidence of acute complications. CONCLUSIONS: Elderly patients with impaired cognitive function should take part in specialized structured TTP. This leads to both better satisfaction with the education programme and an improved ability for diabetes self-management. 相似文献
102.
屈光性调节性内斜视综合治疗的效果 总被引:2,自引:2,他引:0
①目的:探讨综合治疗屈光性调节性内斜视的效果及其相关因素。②方法:对随机收集78例屈光性调节性内斜视病儿的综合治疗效果进行回顾性分析。③结果:经5年随访,73例(93.6%)维持正常眼位,149只(97.4%)弱视眼治愈,72例(92.3%)获得立体视功能。④结论:及时对屈光性调节性内斜视病儿进行综合治疗,建立和恢复其双眼单视功能,预后较好。 相似文献
103.
经皮肾囊穿刺封闭术治疗难治性肾病综合征临床研究 总被引:1,自引:0,他引:1
目的 探讨介入疗法对难治性肾病综合征 (RNS)的疗效。方法 将 6 4例RNS随机分为A ,B两组 ,A组 32例 ,经皮肾囊穿刺向每一肾脂肪囊 (肾囊 )内注入 2 %利多卡因 ,每周 2次 ,同时口服强的松、洛汀新、潘生丁等治疗 ,B组 32例 ,应用强的松、洛汀新、潘生丁等治疗。结果 A组总有效率为 84 .4 % ,B组为 6 5 .6 % ,两组比较 (P <0 .0 5 ) ,A组 1年内复发率低 ,为 2 9.6 % ,B组为 71.4 % ,比较两组 (P <0 .0 1)。结论 利多卡因经皮肾囊内穿刺注射封闭疗法是目前治疗RNS最有效的方法之一 ,值得临床进一步的推广应用。 相似文献
104.
105.
106.
Geste antagonistes, or sensory tricks, are well described in focal dystonia affecting the neck, hand, and face. Improvement in dystonic movements is typically maintained while the trick is performed, but disappears when the geste ends. We investigated the phenomenological features of geste antagoniste maneuvers in 19 patients with idiopathic lower cranial dystonia who were prospectively evaluated over a period of 6 years. Of the 19, 10 were men, mean age of onset was 49.8 years, and the most commonly involved lower cranial area was the jaw (10 patients). In most patients, dystonia was task-specific. Taking advantage of the improvement with a sensory geste, we manufactured oral appliances that mimicked the geste in 8 patients, and 3 continue to use it. 相似文献
107.
Abstract End-stage liver disease caused by the hepatitis C virus is a major indication for liver transplantation. However, recurrence of hepatitis in the graft is a major issue. HCV re-infection after transplantation is almost constant, and recent data confirm that it significantly impairs patient and graft survival. Factors that may influence disease severity and consequent progression of HCV graft injury remain unclear. Chronic HCV infection develops in 60%–80% of patients, and 6%–28% ultimately progress to cirrhosis within 5 years. Pre-transplantation antiviral treatment is not easily related to poor tolerance. Attempts to administer prophylactic post-transplantation antiviral treatment are under evaluation but are limited by antiviral drug side effects. Treatment of established graft lesions with interferon or ribavirin as single agents has been disappointing. Combination therapy gave promising results, with sustained virological response in 25% of patients, but indications, modality and duration of treatment should be assessed. 相似文献
108.
Gabriel Mircescu Dimitrie Capsa Maria Covic Mirela Gherman Caprioara Gheorghe Gluhovschi Ovidiu Golea Nicolae Ursea Liliana Garneata Vasile Cepoi Nicolae Constantinovici Adrian Covic 《Nephrology, dialysis, transplantation》2004,19(12):2971-2980
INTRODUCTION. This report describes the current status of nephrology and renal replacement therapy (RRT) in Romania, a country with previously limited facilities, highlighting national changes in the European context. METHODS: Trends in RRT development were analysed in 2003, on a national basis, using the same questionnaires as in previous surveys (1991, 1995). Survival data and prognostic risk factors were calculated retrospectively from a large representative sample of 2284 patients starting RRT between January 1, 1995 and December 31, 2001 (44% of the total RRT population investigated). RESULTS: In 2003, RRT incidence [128 per million population (p.m.p.)] and prevalence (250 p.m.p.) were six and five times higher, respectively, than in 1995. The annual rate of increase in the stock of RRT patients (11%) was supported mainly by an exponential development of the continuous ambulatory peritoneal dialysis (CAPD) population (+600%), while the haemodialysis (HD) growth rate was stable (+33%) and renal transplantation made a marginal contribution. Renal care infrastructure followed the same trend: nephrology departments (+100%) and nephrologists (+205%). The characteristics of RRT incident patients changed accordingly to current European epidemiology (increasing age and prevalence of diabetes and nephroangiosclerosis). The estimated overall survival of RRT patients in Romania was 90.6% at 1 year [confidence interval (CI) 89.4-91.8] and 62.2% at 5 years (CI 59.4-65.0). Patients' survival was negatively influenced (Cox regression analysis) by age >65 years (P < 0.001), lack of pre-dialysis monitoring by a nephrologist [P = 0.01, hazards ratio (HR) = 0.8], severe anaemia, lack of erythropoetin treatment (P < 0.001, HR = 0.6), and co-morbidity, e.g. cardiovascular diseases (P < 0.001, HR = 1.8) and diabetes mellitus (P < 0.001, HR = 2.2). CONCLUSIONS: Although the rate of increase in RRT patient stock in 1996-2003 in Romania was the highest in Europe, the prevalence remained below the European mean. As CAPD had the greatest expansion, followed by HD, an effective transplantation programme must be set up to overcome the imbalance. The quality of RRT appears to be good and survival was similar to that in other registries. Further evolution implies strategies of prevention, based on national surveys, supported by the Romanian Renal Registry. 相似文献
109.
YUKIO HOMMA HIDEYUKI AKAZA KIYOKI OKADA MASAO YOKOYAMA MICHIYUKI USAMI YOSHIHIKO HIRAO TOMOYASU TSUSHIMA ATSUHIKO SAKAMOTO YASUO OHASHI YOSHIO ASO THE PROSTATE CANCER STUDY GROUP 《International journal of urology》2004,11(4):218-224
BACKGROUND: We retrospectively compared the 5-year survival rates of T1b-T3N0M0 prostate cancer patients treated either by endocrine therapy plus radical prostatectomy or endocrine therapy alone. METHODS: Clinical T1b-T3N0M0 prostate cancer patients were enrolled at 104 institutions in Japan. They were assigned to study 1 (n = 176), if they were indicated to prostatectomy, if not indicated, they were assigned to study 2 (n = 151). The indication of prostatectomy was based on the clinical judgement of physicians and/or patients. Those assigned to study 1 underwent prostatectomy and adjuvant endocrine therapy with or without preoperative androgen deprivation. Those assigned to study 2 were treated with leuprorelin acetate with or without chlormadinone acetate. They were followed-up every 3 months until death or for 5 years and over. RESULTS: Those assigned to study 1 were younger (mean age 67.2 vs 75.7 years), less advanced in clinical stage, and had lower prostate specific antigen levels (mean 43.8 vs 103.6 ng/mL). Death for any reason was observed less frequently in study 1 (n = 29, 16%) than study 2 (n = 50, 33%), and the 5-year overall survival rate was higher in study 1 (87 vs. 68%). However, prostate cancer deaths were comparatively seldom (9% in study 1 and 7% in study 2), resulting in the identical 5-year cause specific survival rate in both study groups (91%). In both study groups the overall survival was almost equal to the natural survival of age-matched men. CONCLUSIONS: Endocrine therapy offers a reasonable survival rate in T1b-T3 prostate cancer patients within a 5-year follow-up. Observation will be extended to determine 10-year outcomes. 相似文献
110.
目的总结瓣膜置换患者行胆道手术的术前用药方法。方法对38例瓣膜置换后在服用华法令过程中因胆道疾病需行择期手术治疗的患者随机分为2组,肝功能正常组(A组)23例、肝功能不正常组(B组)15例均于术前3d停服华法令,B组术前12h肌注VitK110mg。术前无应用华法令历史的患者115例做为对照组。结果38例患者停药2d后A组血浆凝血酶原时间与对照组差异无显著意义,B组于术前12h肌注VitK110mg后,血浆凝血酶原时间与对照组相比差异也无显著性意义。结论瓣膜置换患者在抗凝期间行胆道手术,只要准备充分,围手术期是安全的。 相似文献